Literature DB >> 28904256

Current Surgical Outcomes of Congenital Heart Surgery for Patients With Down Syndrome in Japan.

Takaya Hoashi1, Norimichi Hirahara1, Arata Murakami1, Yasutaka Hirata1, Hajime Ichikawa1, Junjiro Kobayashi1, Shinichi Takamoto1.   

Abstract

BACKGROUND: Current surgical outcomes of congenital heart surgery for patients with Down syndrome are unclear.Methods and 
Results: Of 29,087 operations between 2008 and 2012 registered in the Japan Congenital Cardiovascular Surgery Database (JCCVSD), 2,651 were carried out for patients with Down syndrome (9%). Of those, 5 major biventricular repair procedures [ventricular septal defect repair (n=752), atrioventricular septal defect repair (n=452), patent ductus arteriosus closure (n=184), atrial septal defect repair (n=167), tetralogy of Fallot (TOF) repair (n=108)], as well as 2 major single ventricular palliations [bidirectional Glenn (n=21) and Fontan operation (n=25)] were selected and their outcomes were compared. The 90-day and in-hospital mortality rates for all 5 major biventricular repair procedures and bidirectional Glenn were similarly low in patients with Down syndrome compared with patients without Down syndrome. On the other hand, mortality after Fontan operation in patients with Down syndrome was significantly higher than in patients without Down syndrome (42/1,558=2.7% vs. 3/25=12.0%, P=0.005).
CONCLUSIONS: Although intensive management of pulmonary hypertension is essential, analysis of the JCCVSD revealed favorable early prognostic outcomes after 5 major biventricular procedures and bidirectional Glenn in patients with Down syndrome. Indication of the Fontan operation for patients with Down syndrome should be carefully decided.

Entities:  

Keywords:  Congenital heart surgery; Databases; Down syndrome; Pulmonary hypertension

Mesh:

Year:  2017        PMID: 28904256     DOI: 10.1253/circj.CJ-17-0483

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Effect of Trisomy 21 on Postoperative Length of Stay and Non-cardiac Surgery After Complete Repair of Tetralogy of Fallot.

Authors:  Eric T Purifoy; Beverly J Spray; Joe S Riley; Parthak Prodhan; Elijah H Bolin
Journal:  Pediatr Cardiol       Date:  2019-09-07       Impact factor: 1.655

2.  Long-Term Survival and Causes of Death in Children with Trisomy 21 After Congenital Heart Surgery.

Authors:  Jennifer K Peterson; Lazaros K Kochilas; Jessica Knight; Courtney McCracken; Amanda S Thomas; James H Moller; Shaun P Setty
Journal:  J Pediatr       Date:  2020-12-24       Impact factor: 4.406

3.  Trisomy 21 Patients Undergoing Cavopulmonary Connections Need Improved Preoperative and Postoperative Care.

Authors:  Philip Allen; Brett R Anderson; Emile Bacha; Damien J LaPar
Journal:  Ann Thorac Surg       Date:  2020-11-06       Impact factor: 5.102

4.  Atrial Septal Defect with Down Syndrome and Postsurgical Pulmonary Hypertension.

Authors:  Kyung Lim Yoon
Journal:  J Cardiovasc Imaging       Date:  2019-10

5.  Predictors of major adverse events and complications after ventricular septal defects surgical closure in children less than 10 kg.

Authors:  Ayman R Abdelrehim; Mustafa Al-Muhaya; Alassal A Alkodami; Luna S Baangood; Mansour Al-Mutairi; Abdul Quadeer; Fath A Alabsi; M Alashwal; Mohamed Mofeed F Morsy; Abdulhameed A Alnajjar; Sherif S Salem
Journal:  J Cardiothorac Surg       Date:  2022-09-07       Impact factor: 1.522

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.